Skin Conditions Remain Prevalent in People with HIV Despite Advances in Treatment

A new study by researchers at the George Washington University has found that nearly half of people living with HIV experience skin conditions, despite the advances in HIV treatment. The study, which examined medical records from 11,738 adults in Washington, D.C., between 2011 and 2023, highlights the need for ongoing, targeted dermatologic care, especially as people with HIV live longer, healthier lives.

Key Takeaways:

  • The study found that 49% of participants had at least one dermatologic diagnosis, with infectious conditions such as fungal infections, herpes, and viral warts being the most common.
  • New skin condition diagnoses decreased sharply over the past decade, reflecting progress in HIV treatment.
  • Patients receiving care in community settings and those with public insurance were more likely to be diagnosed with dermatologic disease, underscoring structural barriers to specialized care.
  • The study highlights the need for integrating dermatology into HIV care to provide comprehensive support for both overall health and quality of life.
  • Early diagnosis and prompt initiation of HIV treatment remain critical for reducing the long-term risk of both infectious and malignant skin conditions.

Statistics:

  • 49% of participants had at least one dermatologic diagnosis.
  • New skin condition diagnoses decreased by X% over the past decade (2011-2023).
  • 11,738 adults were examined in the study.
  • The study was conducted in Washington, D.C. between 2011 and 2023.
  • Patients receiving care in community settings were X% more likely to be diagnosed with dermatologic disease.
  • Those with public insurance were X% more likely to be diagnosed with dermatologic disease.

Sources:

  • George Washington University, "New Study Finds Skin Conditions Remain Prevalent in People with HIV Despite Advances in Treatment", October 14, 2025.
  • The study, “Prevalence, Incidence, and Risk Factors for Dermatologic Conditions in People with HIV in the Modern Antiretroviral Era”.